Pre-Basal Insulin Analog Era: Paving the Way for Modern Day Basal Insulins.


Journal

The Journal of the Association of Physicians of India
ISSN: 0004-5772
Titre abrégé: J Assoc Physicians India
Pays: India
ID NLM: 7505585

Informations de publication

Date de publication:
Dec 2020
Historique:
entrez: 28 11 2020
pubmed: 29 11 2020
medline: 2 12 2020
Statut: ppublish

Résumé

Prior to the discovery of insulins, diabetes was managed predominantly by dietary interventions. Discovery of insulin and its first human trial highlighted the need for higher purity insulin thereby steering the subsequent journey of insulin development. Considering the limitations of the early preparations like short duration of action and need for several injections per day, attempts at protracting the duration of insulin action were made. This led to the development of intermediate-acting Neutral Protamine Hagedorn (NPH) and the Lente family of insulins. This review provides insights into the discovery of insulins and the shortcomings of early protracted release preparations, which in turn, gave impetus to the search for a 'true' basal insulin, which could mimic the endogenous human basal insulin secretion.

Identifiants

pubmed: 33247657

Substances chimiques

Hypoglycemic Agents 0
Insulin 0
Insulin, Long-Acting 0
Insulins 0

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

9-12

Informations de copyright

© Journal of the Association of Physicians of India 2011.

Auteurs

Mangesh Tiwaskar (M)

Senior Consultant, Shilpa Medical Research Center, Mumbai, Maharashtra.

Prasun Deb (P)

Head, Department of Endocrinology, KIMS Hospital, Hyderabad, Telangana.

Rajesh Khadgawat (R)

Professor, Department of Endocrinology, All India Institute of Medical Sciences, Delhi.

L Sreenivasamurthy (L)

Consultant, Life care clinic and research center, Bengaluru, Karnataka.

Nilakshi Deka (N)

Consultant, Apollo Hospital, Guwahati, Assam.

B Karthik (B)

Assistant Professor, Endocrinology, Sri Ramachandra Medical College, Chennai, Tamil Nadu.

Ashwin Karuppan (A)

Consultant, Tambaram Medical Centre, Chennai, Tamil Nadu.

Dipanjan Bhattacharjee (D)

Medical Affairs, Diabetes and Cardiovascular, Sanofi India Ltd.

Viswanathan Mohan (V)

Chairman and Chief Diabetologist, Dr. Mohan's Diabetes Specialities Centre, Chennai, Tamil Nadu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH